Dr. Purvi Kadakia Kutty

• MBBS: Leading Medical College, India
• MD (Paediatrics): Leading Medical College, India

• Fellowship in Paediatric Haematology & Oncology: Indian Academy of Paediatrics (IAP)
• FNB (Fellowship of National Board): Paediatric Haematology & Oncology

• DCH: Diploma in Child Health
• Registered with the Medical Council of India (MCI) and Maharashtra Medical Council.

• Acute Lymphoblastic Leukaemia (ALL)
• Acute Myeloid Leukaemia (AML)
• Hodgkin’s and Non-Hodgkin’s Lymphoma
• Neuroblastoma
• Wilms’ Tumour
• Retinoblastoma
• Bone Tumours (Osteosarcoma, Ewing’s Sarcoma)

• Paediatric Bone Marrow Transplantation (BMT)
• Benign Haematology (Thalassemia, Sickle Cell Disease, Aplastic Anaemia)
• Primary Immune Deficiency Disorders
• Haemophilia and Bleeding Disorders
• Nutritional Oncology

• Allogeneic Stem Cell Transplantation (Matched Sibling & Unrelated Donor)
• Autologous Stem Cell Transplantation
• Intrathecal Chemotherapy
• Bone Marrow Aspiration and Biopsy
• Central Line Insertions (Hickman/PICC) for Chemotherapy

Current & Past Hospital Affiliations

Current Affiliation:

• Senior Consultant – Hemato Oncology, Apollo Cancer Centres, Navi Mumbai
• Consultant, NewEra Hospitals, Vashi (Founder Member)
• Consultant, Apollo Hospitals, Belapur
• Consultant, Neuro One, Kharghar

Past Affiliations:

• Honorary Visiting Consultant, Division of Paediatric Haematology-Oncology, Lokmanya Tilak Municipal General Hospital (LTMGH), Sion Hospital, Mumbai.

Academic & Research Roles

• Active member of the Indian Paediatric Oncology Group (InPOG), contributing to national registries and studies.
• Mentor and guide for postgraduate students in Paediatrics and Haematology.
• Regular speaker at national conferences regarding advances in Paediatric BMT and Thalassemia management.

Key Achievements & Contributions

• Instrumental in setting up the Paediatric Hemato-Oncology and BMT department at NewEra Hospitals.
• Recognised for extensive work in Thalassemia management and "Thalassemia Free" initiatives through BMT.
• Contributed significantly to the InPOG COVID-19 registry, analysing the impact of the pandemic on children with cancer.

National & International Awards

• Recognised as a Leading Paediatric Oncologist in India for her contribution to establishing BMT services in Navi Mumbai.
• Acknowledged for her research contributions by the Indian Academy of Paediatrics (IAP).

Recognitions & Honors

• Founder Member of NewEra Hospitals, Vashi.
• Invited faculty at various national Haematology and Oncology conferences.

Dr. Purvi Kadakia Kutty has published over 49 research papers. Below are selected key publications:

Published Papers in Medical Journals

• Congenital Dyserythropoietic Anaemia Mimicking Hereditary Spherocytosis: Navigating a Diagnostic Challenge (Journal Name Not Listed, 2025)
• Clinical profile of Fanconi anemia in a tertiary care center in Western India: A single centre experience (Journal Name Not Listed, 2025)
• Outcomes of COVID-19 in children with cancer – Report from the Indian Pediatric Oncology Group (InPOG) COVID-19 registry in India (Indian Journal of Pediatrics, 2022)
• Role of hydroxyurea in non-transfusion dependent thalassemia – A prospective study (Journal Name Not Listed, 2023)
• Sleep disturbances and childhood cancer - A tertiary care experience (Journal Name Not Listed, 2022)
• Transient myeloproliferative disorder: A pointer to underlying trisomy 21 (Journal Name Not Listed, 2019)
• Clinical Profile & Quality Of Life In Transfusion Dependent Thalassemia Patients - Post Splenectomy (Journal Name Not Listed, 2018)

Ongoing Clinical Trials Participation

• Active participant in InPOG studies related to childhood cancer survivorship (C2S Study) and leukaemia management protocols.

Notable Cases Handled

• Curing Thalassemia Major: Dr. Kutty has performed numerous successful Bone Marrow Transplants for children with Thalassemia Major, allowing them to lead a transfusion-free life.
• Relapsed Leukaemia Management: She successfully treated a young patient with relapsed Acute Lymphoblastic Leukaemia using a high-risk protocol and subsequent Allogeneic BMT, achieving long-term remission.
• Rare Genetic Disorders: Successfully diagnosed and managed a rare case of Congenital Dyserythropoietic Anaemia that was previously misdiagnosed, significantly improving the child's quality of life.

Patient Testimonials & Feedback

Freedom from Thalassemia Major

• For parents of children born with Thalassemia Major, the prospect of lifelong blood transfusions is daunting. Dr. Kutty has successfully performed numerous Allogeneic Bone Marrow Transplants, offering a curative solution. Families of these young patients frequently describe the transition to a "transfusion-free life" as miraculous, praising Dr. Kutty’s meticulous donor selection process and her vigilance during the critical post-transplant isolation period.

Victory Over Childhood Leukaemia

• A diagnosis of Acute Lymphoblastic Leukaemia (ALL) is devastating for any family. Parents whose children have achieved remission under Dr. Kutty’s care often highlight her ability to demystify complex chemotherapy protocols. Her approach is frequently described as "deeply empathetic," with testimonials noting how she becomes a pillar of emotional strength for the family while guiding the child gently through the rigours of long-term treatment.

Compassionate Care for Sickle Cell Warriors

• Children suffering from Sickle Cell Disease often face debilitating pain crises that disrupt their schooling and childhood. Dr. Kutty is highly regarded for her proactive pain management strategies and long-term care plans. Parents express gratitude for her focus on "holistic well-being," noting that under her supervision, the frequency of hospital admissions has dropped significantly, allowing their children to lead active, normal lives.

Patient-Centred Care

• Dr. Kutty adopts a compassionate, family-centred approach. She understands that a child’s cancer diagnosis affects the entire family. Her practice emphasizes clear communication, psychological support, and nutritional guidance to ensure the child maintains growth and development during treatment.

Technology & Innovation

• She utilises the latest protocols for chemotherapy and immunotherapy. In the realm of Bone Marrow Transplantation, she employs advanced HLA typing and conditioning regimens to reduce toxicity and improve graft survival rates, making transplants safer for paediatric patients.

The cost of paediatric oncology procedures can vary based on the complexity of the case, donor type (for BMT), and duration of hospital stay.

Note: These are estimated costs. For appointment booking and to get a personalised cost estimate, you can connect with the Cancer Rounds team.

Language Support

• The Cancer Rounds team provides dedicated language interpretation services to ensure that international families fully understand the diagnosis and treatment plan for their children.

Visa & Travel Assistance

• Cancer Rounds assists with Medical Visa letters, priority appointments, airport transfers, and finding child-friendly accommodation near the hospital for long-term stays during BMT recovery.

Pre-treatment Virtual Consultations

• Parents can schedule video consultations with Dr. Purvi Kadakia Kutty via Cancer Rounds to discuss medical reports and treatment feasibility before travelling to India.